Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot Study

Phase: PHASE1 | Sponsor: University Health Network, Toronto | Compound: Psilocybin

Status

recruiting

Institution

University Health Network, Toronto

Start date

2024-10-09

End date

2027-01-01

Registry ID

NCT06506019

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.